Our analyses on hallmark alterations in glioma genome show that LOH of 1p and 19q is more frequent in PDGFRA-high gliomas, and that EGFR amplification is more frequent in PDGFRA-low and PDGFRA-intermediate gliomas. Here, PDGFRA is linked to central nervous system cancer.